Updated 5-year local control (LC), metastasis-free survival (MFS), and overall survival (OS) data from a phase I study of nilotinib plus radiation (RT) in high-risk chordoma Meeting Abstract
| Authors: | Cote, G. M.; DeLaney, T. F.; Miao, R.; Schwab, J. H.; Raskin, K.; Calderon, S. L.; Mullen, J. T.; Haynes, A. B.; Hornicek, F. J.; Chen, Y. L.; Choy, E. |
| Abstract Title: | Updated 5-year local control (LC), metastasis-free survival (MFS), and overall survival (OS) data from a phase I study of nilotinib plus radiation (RT) in high-risk chordoma |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368308373 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.e23505 |
| Notes: | Meeting Abstract: e23505 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work